sever
acut
respiratori
syndrom
sar
emerg
infecti
diseas
caus
novel
coronaviru
cov
design
sarsassoci
cov
sarscov
three
known
antigen
group
cov
associ
diseas
anim
human
known
human
cov
hcov
cov
group
cov
group
gener
recogn
caus
mild
upper
respiratori
tract
diseas
rare
lower
respiratori
tract
diseas
phylogenet
analys
show
sarscov
close
relat
previous
character
cov
howev
investig
use
vero
cell
immunohistochem
antibodi
test
observ
crossreact
sarscov
group
cov
seroepidemiolog
studi
reveal
crossreact
vero
cell
pair
serum
sampl
patient
respect
serum
sampl
group
covinfect
anim
also
crossreact
recombin
nucleocapsid
protein
sarscov
result
recombin
nucleocapsid
elisa
posit
serum
sampl
healthi
blood
donor
natur
antigen
crossreact
still
unknown
present
studi
clone
nucleocapsid
gene
sarscov
produc
specif
anim
antisera
determin
nucleocapsid
protein
respons
observ
antigen
crossreact
addit
antigen
relationship
among
sarscov
studi
use
serum
sampl
healthi
donor
patient
sar
subject
materi
method
hcov
strain
atcc
atcc
maintain
normal
human
fetal
lung
fibroblast
cell
atcc
african
green
monkey
kidney
cell
atcc
mem
gibco
brl
supplement
fetal
bovin
serum
gibco
brl
sarscov
strain
isol
patient
sar
hong
kong
inocul
vero
cell
describ
elsewher
experi
live
virus
perform
biosafeti
level
laboratori
murin
monoclon
antibodi
specif
nucleocapsid
protein
obtain
commerci
sourc
chemicon
intern
amurinemonoclon
antibodi
specif
nucleocapsid
protein
sarscov
produc
laboratori
antiserum
whole
viru
prepar
femal
new
zealand
white
rabbit
describ
elsewher
cdna
fragment
nucleocapsid
protein
cov
clone
prokaryot
express
vector
qiagen
frame
upstream
histidin
residu
seri
nucleocapsid
protein
express
purifi
use
ninta
affin
column
qiagen
accord
manufactur
instruct
express
recombin
nucleocapsid
protein
identifi
western
blot
analysi
describ
elsewher
igg
identifi
use
commerci
avail
indirect
immunofluoresc
assay
ifa
kit
euroimmun
accord
manufactur
instruct
igg
identifi
inhous
ifa
describ
elsewher
modifi
use
cell
cell
respect
igm
igg
antibodi
sarscov
identifi
use
elisa
test
kit
huada
gbi
biotechnolog
accord
manufactur
instruct
nucleocapsid
elisa
perform
describ
elsewher
ensur
biosafeti
experi
use
serum
sampl
patient
perform
biosafeti
level
laboratori
one
hundr
serum
sampl
collect
randomli
healthi
adult
donor
octob
serum
sampl
collect
patient
sar
day
onset
symptom
pair
serum
sampl
obtain
patient
exhibit
seroconvers
tabl
acut
convalescentphas
serum
sampl
collect
day
day
onset
symptom
sar
diagnos
accord
world
health
organ
criteria
confirm
assess
seroconvers
increas
antibodi
titer
sarscov
ifa
result
full
length
nucleocapsid
gene
sarscov
amplifi
correspond
primer
pair
gene
size
bp
sarscov
respect
recombin
plasmid
sequenc
frame
sequenc
match
nucleocapsid
gene
cov
express
recombin
ntermin
nucleocapsid
protein
identifi
western
blot
analysi
use
antihi
monoclon
antibodi
immunoreact
protein
band
expect
size
shown
figur
nucleocapsid
protein
sarscov
react
strongli
specif
rabbit
serum
immun
correspond
nucleocapsid
protein
immunoreact
protein
band
western
blot
figur
crossreact
demonstr
among
nucleocapsid
protein
sarscov
result
indic
substanti
antigen
crossreact
occur
among
nucleocapsid
protein
sarscov
immun
rabbit
serum
use
rabbit
serum
react
strongli
cell
moder
cell
weakli
cell
ifa
convers
rabbit
serum
react
strongli
cell
react
either
sarscov
cell
rabbit
serum
react
strongli
cell
strongli
cell
react
cell
furthermor
rabbit
serum
show
weak
fluoresc
signal
uninfect
cell
compar
respons
nonimmun
rabbit
serum
determin
serolog
respons
nucleocapsid
protein
cov
serum
sampl
collect
healthi
donor
serum
sampl
collect
patient
sar
test
recombin
nucleocapsid
protein
sarscov
use
western
blot
analysi
serum
sampl
healthi
donor
show
strong
reactiv
nucleocapsid
protein
posit
result
sampl
respect
sampl
react
sarscov
nucleocapsid
protein
contrast
serum
sampl
patient
sar
obtain
day
onset
symptom
show
strong
immunoreact
nucleocapsid
protein
sarscov
posit
result
sampl
respect
covinfect
cell
use
result
posit
igg
antibodi
ifa
sarscov
serum
sampl
healthi
donor
two
sampl
healthi
donor
antibodi
respons
ifa
antibodi
respons
nucleocapsid
protein
western
blot
analysi
one
sampl
collect
octob
antibodi
respons
sarscov
ifa
nucleocapsid
protein
sarscov
western
blot
analysi
howev
sampl
patient
sar
antibodi
respons
sarscov
healthi
donor
result
ifa
show
presenc
antibodi
respons
nucleocapsid
protein
associ
presenc
igg
antibodi
hcov
antibodi
sarscov
absent
sampl
except
low
antibodi
titer
compar
usual
antibodi
titer
least
patient
sar
serum
sampl
patient
sar
antibodi
respons
sarscov
well
nucleocapsid
protein
use
western
blot
analysi
cell
use
ifa
pair
serum
sampl
patient
sar
use
determin
antigen
relationship
among
cov
ifa
elisa
antibodi
titer
sarscov
shown
tabl
determin
viral
antigen
respons
crossreact
cultur
filtrat
cell
infect
immunoblot
pair
serum
sampl
strong
band
kda
molecular
weight
reaction
specif
monoclon
antibodi
nucleocapsid
protein
observ
convalesc
phase
sampl
patient
sar
figur
serum
sampl
also
display
higher
antibodi
titer
nucleocapsid
elisa
pair
serum
sampl
patient
also
weak
moder
reactiv
band
kda
immunoblot
acutephas
convalescentphas
serum
pair
serum
sampl
weak
reactiv
band
kda
molecular
weight
reaction
specif
monoclon
antibodi
nucleocapsid
protein
immunoblot
data
shown
discuss
result
indic
nucleocapsid
protein
antigen
crossreact
found
sarscov
rabbit
serum
immun
either
previou
studi
neither
specif
monoclon
polyclon
antibodi
nucleocapsid
protein
sarscov
crossreact
howev
previou
studi
describ
crossreact
nucleocapsid
protein
sarscov
group
cov
crossreact
may
depend
type
serum
use
anoth
investig
demonstr
anim
serum
crossreact
sarscov
present
studi
use
immunofluoresc
stain
covinfect
cell
rabbit
serum
crossreact
cell
wherea
rabbit
serum
moder
crossreact
cell
weak
crossreact
cell
although
rabbit
serum
high
antibodi
titer
sarscov
slightli
contamin
antibodi
host
cell
compon
appar
serum
crossreact
addit
ifa
show
rabbit
serum
strong
crossreact
crossreact
observ
investig
other
possibl
antibodi
rabbit
serum
react
host
cell
crossreact
known
hcov
respons
common
cold
unexpect
serum
sampl
healthi
donor
antibodi
respect
therefor
expect
antibodi
found
serum
sampl
patient
sar
either
preexist
crossreact
antibodi
studi
issu
warrant
ifa
show
pair
serum
sampl
exhibit
increas
antibodi
titer
patient
sar
respect
high
antibodi
titer
respons
known
hcov
patient
sar
may
repres
anamnest
reaction
previou
infect
known
hcov
cov
crossreact
sarscov
howev
nucleocapsid
elisa
detect
increas
antibodi
titer
pair
serum
sampl
patient
sar
nucleocapsid
protein
use
antigen
consist
increas
signal
reaction
nucleocapsid
protein
cell
cultur
filtrat
western
blot
analysi
figur
pair
serum
sampl
patient
sar
show
consist
increas
antibodi
titer
nucleocapsid
elisa
increas
signal
reaction
nucleocapsid
protein
cell
cultur
filtrat
western
blot
analysi
result
confirm
suggest
major
antigen
crossreact
convalescentphas
serum
sampl
patient
sar
due
nucleocapsid
protein
viral
compon
although
pair
serum
sampl
patient
sar
show
partial
crossreact
signific
close
correl
ifa
titer
ratio
determin
respons
whole
cell
elisa
titer
ratio
determin
respons
nucleocapsid
protein
furthermor
antibodi
sarscov
could
detect
serum
sampl
healthi
donor
either
ifa
nucleocapsid
western
blot
analysi
even
though
patient
sar
antibodi
therefor
serolog
crossreact
sarscov
healthi
donor
even
though
high
reactiv
hcov
summari
sarscov
appar
antigen
crossreact
known
hcov
although
clear
antigen
determin
involv
overal
result
suggest
sarscov
close
antigen
relat
sarscov
studi
use
number
purifi
recombin
viral
compon
cov
antigen
identifi
antibodi
produc
infect
determin
antigen
relationship
among
cov
progress
